PCI Pharma Services: A global pharmaceutical manufacturing company that develops, manufactures, and packages life-changing therapies for patients all around the world is expanding its campus in Bedford.
Originally posted in Union Leader in May 2022
PCI Pharma Services acquired Bedford-based life sciences provider Lyophilization Services of New England (LSNE) in December 2021. Following that acquisition, PCI now has its sights on a major expansion plan, with the construction of a 50,000-square-foot facility.
“The 50,000-square-foot facility will be an extension to one of our existing facilities in Bedford,” said Bryan Koeppl, senior vice president of transformation at PCI. “It will be located in Commerce Park, with construction slated for completion in the summer of 2024“.